Xospata Prices, Coupons, Copay Cards & Patient Assistance
Xospata (gilteritinib) is a member of the multikinase inhibitors drug class and is commonly used for Acute Myeloid Leukemia.
Xospata is available as a brand name drug only, a generic version is not yet available. View generic Xospata availability for more details.
Xospata prices
Oral Tablet
40 mg Xospata oral tablet from $28,314.72 for 90 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 90 | $314.61 | $28,314.72 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Xospata Coupons, Copay Cards and Rebates
Xospata offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Xospata Patient Savings Program
Eligible commercially insured patients may pay $0 per prescription; patients enrolled in the program for a 12-month period.
- Applies to:
- Xospata
- Number of uses:
- Per 12 month period
Form more information phone: 844-632-9272 or Visit website
Patient Assistance & Copay Programs for Xospata
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: HealthWell Foundation Copay Program
Eligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
- Xospata (gilteritinib) Tablet
More information please phone: 800-675-8416 Visit website
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Xospata (gilteritinib) Tablet
More information please phone: 866-316-7263 Visit website
Provider: Astellas Pharma Support Solutions: XOSPATA
Eligibility requirements:- Must be uninsured or rendered uninsured
- Not disclosed
- FDA-approved diagnosis
- Must have a verifiable US shipping address and be treated by US Doctor
- Please visit www.astellaspharmasupportsolutions.com for more information This program also provides copay assistance. Support offered to patients who are prescribed Xospata.
- Xospata (gilteritinib) Tablet
More information please phone: 844-632-9272 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Vidaza
Vidaza is used to treat certain types of bone marrow cancers and blood cell disorders. Learn about ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Tibsovo
Tibsovo (ivosidenib) is a once-daily oral medication that targets a specific gene mutation called ...
Ivosidenib
Ivosidenib is used for acute myeloid leukemia, biliary tract tumor, myelodysplastic syndrome
Idarubicin
Idarubicin is used for acute myeloid leukemia, leukemia, leukocytoclastic vasculitis, solid tumors
Daunorubicin
Daunorubicin is used for acute lymphocytic leukemia, acute myeloid leukemia, acute nonlymphocytic ...
Midostaurin
Midostaurin is used for acute myeloid leukemia, systemic mastocytosis
Azacitidine
Azacitidine is used for acute myeloid leukemia, myelodysplastic syndrome
Cytarabine
Cytarabine is used for acute myeloid leukemia, acute nonlymphocytic leukemia, chronic myelogenous ...
More about Xospata (gilteritinib)
- Check interactions
- Compare alternatives
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español